In conjunction with GPIIb/IIIa, stimulation of P2Y12 receptor can promote platelet-tumor crosstalk and cancer metastasis (Figure 2), suggesting P2Y12 receptor antagonists as anticancer drugs (73, 201). This evidence concerns the gene ITGA2B and cancer.